---

The drug discovery and development process is highly time-consuming and risky business and therefore, there is a significant quest to develop new scientific approaches to identify correlations between the nature of the drug and of its safety and efficacy in the human body (pharmacovigilance-based) so that potentially challenging drug leads could be recognized and eradicated at the earliest stages in their development, which will improve the public health and provide a safe, effective and rational use of medicines. This book is based on the importance and implication of Pharmacovigilance in the drug discovery and development process. It highlights a brief description on the role played by Pharmacovigilance at various stages of drug development, such as, risk management, clinical practice, drug regulation.

---

Dr. Prashansa Agrawal has received her PhD in Biotechnology from Indian Institute of Technology Roorkee, India. Currently, she is working as Research Associate at University of Arizona. Her research work involves studying cancer-specific molecular target for anticancer drugs involving DNA secondary structures as major target.

---